The Adient Absorbable Vena Cava Filter is intended for the temporary prevention of pulmonary embolism in patients with transient high risk for venous thromboembolism (DVT and/or PE) with or without venous thromboembolic disease and as an enhancement to pharmaceutical anticoagulation and mechanical prophylaxis. The Adient Absorbable Vena Cava Filter does not require retrieval.
Patients requiring temporary prevention of potential pulmonary embolism include major trauma, major orthopedic procedures such as total knee replacement, and patients in surgical ICU. Here the likelihood of PE is substantially higher than the general population and would benefit from an absorbable filter.
Note: The Adient Absorbable Vena Cava Filter is not commercially available. Food and Drug Administration (FDA) approval requires successful completion of the US clinical trial.